Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Ganzina

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Investigational New Drugs|January 1, 1983
Clinical evaluation of 4'-epi-doxorubicin in advanced solid tumorsG Robustelli Della Cuna, L Pavesi, P Preti, et al.
Il Farmaco; Edizione Scientifica|February 1, 1972
Amides of norbornanemethylamine. II. Synthesis and properties of amide derivatives of 2-(2-hydroxyethylaminomethyl)-3-methylnorbornaneD Antoniu, F Ganzina, M Magi, et al.
Investigational New Drugs|January 1, 1984
Phase II study of epirubicin in advanced malignant melanomaM Lopez, C F Perno, P Papaldo, et al.
Investigational New Drugs|January 1, 1984
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanomaM Lopez, C F Perno, L Di Lauro, et al.
Investigational New Drugs|January 1, 1986
Phase II trial with oral idarubicin in advanced breast cancerM Lopez, L Di Lauro, P Papaldo, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1984
A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumorsA Martoni, L Tomasi, G Farabegoli, et al.
Tumori|October 31, 1982
Phase II study of 4'epi-doxorubicinE Ferrazzi, O Nicoletto, O Vinante, et al.
Cancer Treatment Reports|July 1, 1986
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanomaM Lopez, L Di Lauro, P Papaldo, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancerM Lopez, P Vici, S Carpano, et al.
American Journal of Clinical Oncology|April 1, 1985
Epirubicin in non-Hodgkin's lymphomasM Lopez, C F Perno, L Di Lauro, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Investigational New Drugs|January 1, 1983
Clinical evaluation of 4'-epi-doxorubicin in advanced solid tumorsG Robustelli Della Cuna, L Pavesi, P Preti, et al.
Il Farmaco; Edizione Scientifica|February 1, 1972
Amides of norbornanemethylamine. II. Synthesis and properties of amide derivatives of 2-(2-hydroxyethylaminomethyl)-3-methylnorbornaneD Antoniu, F Ganzina, M Magi, et al.
Investigational New Drugs|January 1, 1984
Phase II study of epirubicin in advanced malignant melanomaM Lopez, C F Perno, P Papaldo, et al.
Investigational New Drugs|January 1, 1984
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanomaM Lopez, C F Perno, L Di Lauro, et al.
Investigational New Drugs|January 1, 1986
Phase II trial with oral idarubicin in advanced breast cancerM Lopez, L Di Lauro, P Papaldo, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1984
A phase II study of 4'-epi-doxorubicin plus cis-platinum in advanced solid tumorsA Martoni, L Tomasi, G Farabegoli, et al.
Tumori|October 31, 1982
Phase II study of 4'epi-doxorubicinE Ferrazzi, O Nicoletto, O Vinante, et al.
Cancer Treatment Reports|July 1, 1986
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanomaM Lopez, L Di Lauro, P Papaldo, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1991
Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancerM Lopez, P Vici, S Carpano, et al.
American Journal of Clinical Oncology|April 1, 1985
Epirubicin in non-Hodgkin's lymphomasM Lopez, C F Perno, L Di Lauro, et al.
Pageof 3